Development and Evaluation of a Pilot Nurse Case Management Model to Address Multidrug-resistant Tuberculosis (MDR-TB) and HIV in South Africa

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Nov 19

PMID 25405988

Citations 17

Authors

Jason E Farley

Ana M Kelly

Katrina Reiser

Maria Brown

Joan Kub

Jeane G Davis

Louise Walshe

Martie Van Der Walt

Affiliations

Soon will be listed here.

Abstract

Setting: Multidrug-resistant tuberculosis (MDR-TB) unit in KwaZulu-Natal, South Africa.

Objective: To develop and evaluate a nurse case management model and intervention using the tenets of the Chronic Care Model to manage treatment for MDR-TB patients with a high prevalence of human immunodeficiency virus (HIV) co-infection.

Design: A quasi-experimental pilot programme utilizing a nurse case manager to manage care for 40 hospitalized MDR-TB patients, 70% HIV co-infected, during the intensive phase of MDR-TB treatment. Patients were followed for six months to compare proximal outcomes identified in the model between the pre- and post-intervention period.

Results: The greatest percent differences between baseline and six-month MDR-TB proximal outcomes were seen in the following three areas: baseline symptom evaluation on treatment initiation (95% improvement), baseline and monthly laboratory evaluations completed per guidelines (75% improvement), and adverse drug reactions acted upon by medical and/or nursing intervention (75% improvement).

Conclusion: Improvements were identified in guideline-based treatment and monitoring of adverse drug reactions following implementation of the nurse case management intervention. Further study is required to determine if the intervention introduced in this model will ultimately result in improvements in final MDR-TB treatment outcomes.

Citing Articles

Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes.

Geiger K, Patil A, Budhathoki C, Dooley K, Lowensen K, Ndjeka N PLOS Glob Public Health. 2024; 4(5):e0002714.

PMID: 38709764 PMC: 11073678. DOI: 10.1371/journal.pgph.0002714.

A qualitative exploration of the use of telehealth for opioid treatment: Implications for nurse-managed care.

Heidari O, Winiker A, Pollock S, Sodder S, Tsui J, Tobin K J Clin Nurs. 2024; 33(7):2707-2718.

PMID: 38500003 PMC: 11176020. DOI: 10.1111/jocn.17125.

Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa.

McNabb K, Bergman A, Patil A, Lowensen K, Mthimkhulu N, Budhathoki C BMC Public Health. 2024; 24(1):578.

PMID: 38389038 PMC: 10885440. DOI: 10.1186/s12889-024-17924-0.

Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa.

Geiger K, Patil A, Bergman A, Budhathoki C, Heidari O, Lowensen K Int J Tuberc Lung Dis. 2024; 28(1):42-50.

PMID: 38178293 PMC: 10915896. DOI: 10.5588/ijtld.23.0242.

Successful Multidrug-Resistant Tuberculosis Treatment Without HIV Viral Suppression: A Missed Opportunity.

Geiger K, Patil A, Budhathoki C, Dooley K, Lowensen K, Ndjeka N J Acquir Immune Defic Syndr. 2023; 94(3):253-261.

PMID: 37757847 PMC: 10592374. DOI: 10.1097/QAI.0000000000003268.

References

Brust J, Gandhi N, Carrara H, Osburn G, Padayatchi N . High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003. Int J Tuberc Lung Dis. 2010; 14(4):413-9. PMC: 3005763. View

Farley J, Ram M, Pan W, Waldman S, Cassell G, Chaisson R . Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PLoS One. 2011; 6(7):e20436. PMC: 3142109. DOI: 10.1371/journal.pone.0020436. View

Coleman K, Austin B, Brach C, Wagner E . Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood). 2009; 28(1):75-85. PMC: 5091929. DOI: 10.1377/hlthaff.28.1.75. View

Perumal R, Padayatchi N, Stiefvater E . The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa. BMC Public Health. 2009; 9:243. PMC: 2716340. DOI: 10.1186/1471-2458-9-243. View

Jones D, Weiss S, Chitalu N . HIV Prevention in Resource Limited Settings: A Case Study of Challenges and Opportunities for Implementation. Int J Behav Med. 2014; 22(3):384-92. PMC: 4721251. DOI: 10.1007/s12529-014-9397-3. View

Pooran A, Pieterson E, Davids M, Theron G, Dheda K . What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?. PLoS One. 2013; 8(1):e54587. PMC: 3548831. DOI: 10.1371/journal.pone.0054587. View

Schumann A, Nyamathi A, Stein J . HIV risk reduction in a nurse case-managed TB and HIV intervention among homeless adults. J Health Psychol. 2007; 12(5):833-43. DOI: 10.1177/1359105307080618. View

Harries A, Zachariah R, Corbett E, Lawn S, Santos-Filho E, Chimzizi R . The HIV-associated tuberculosis epidemic--when will we act?. Lancet. 2010; 375(9729):1906-19. DOI: 10.1016/S0140-6736(10)60409-6. View

Gandhi N, Andrews J, Brust J, Montreuil R, Weissman D, Heo M . Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2012; 16(1):90-7. PMC: 3302205. DOI: 10.5588/ijtld.11.0153. View

10.

Shean K, Willcox P, Siwendu S, Laserson K, Gross L, Kammerer S . Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002. Int J Tuberc Lung Dis. 2008; 12(10):1182-9. View

11.

Scano F, Vitoria M, Burman W, Harries A, Gilks C, Havlir D . Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings. Int J Tuberc Lung Dis. 2008; 12(12):1370-5. View

12.

Wells C, Cegielski J, Nelson L, Laserson K, Holtz T, Finlay A . HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007; 196 Suppl 1:S86-107. DOI: 10.1086/518665. View

13.

Anaya H, Hoang T, Golden J, Goetz M, Gifford A, Bowman C . Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. J Gen Intern Med. 2008; 23(6):800-7. PMC: 2517869. DOI: 10.1007/s11606-008-0617-x. View

14.

Pasricha A, Deinstadt R, Moher D, Killoran A, Rourke S, Kendall C . Chronic Care Model Decision Support and Clinical Information Systems interventions for people living with HIV: a systematic review. J Gen Intern Med. 2012; 28(1):127-35. PMC: 3539016. DOI: 10.1007/s11606-012-2145-y. View

15.

Farley J, Tudor C, Mphahlele M, Franz K, Perrin N, Dorman S . A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa. Int J Tuberc Lung Dis. 2012; 16(1):82-9. PMC: 3875139. DOI: 10.5588/ijtld.10.0791. View

16.

Falzon D, Jaramillo E, Schunemann H, Arentz M, Bauer M, Bayona J . WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011; 38(3):516-28. DOI: 10.1183/09031936.00073611. View

17.

Berra K . Does nurse case management improve implementation of guidelines for cardiovascular disease risk reduction?. J Cardiovasc Nurs. 2010; 26(2):145-67. DOI: 10.1097/JCN.0b013e3181ec1337. View

18.

Del Sindaco D, Pulignano G, Minardi G, Apostoli A, Guerrieri L, Rotoloni M . Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. J Cardiovasc Med (Hagerstown). 2007; 8(5):324-9. DOI: 10.2459/JCM.0b013e32801164cb. View

19.

Lin R, Lin F, Wu C, Peng M, Chen P, Kuo H . Effect of a hospital-based case management approach on treatment outcome of patients with tuberculosis. J Formos Med Assoc. 2006; 105(8):636-44. PMC: 7135861. DOI: 10.1016/S0929-6646(09)60162-5. View

20.

Phillips J, Rolley J, Davidson P . Developing Targeted Health Service Interventions Using the PRECEDE-PROCEED Model: Two Australian Case Studies. Nurs Res Pract. 2012; 2012:279431. PMC: 3407641. DOI: 10.1155/2012/279431. View